Trials / Unknown
UnknownNCT03218852
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced Stage IgA Nephropathy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 133 (actual)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is an extended follow-up of the study (ClinicalTrials.gov ID: NCT01758120)-Treatment of prednisone plus cyclophosphamide may be superior to treatment of prednisone alone in patients with advanced-stage IgA nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisone and cyclophosphamide | Prednisone and cyclophosphamide are both administered to participants in this group. |
| DRUG | prednisone alone | Prednisone is administered to participants in this group. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2017-07-17
- Last updated
- 2017-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03218852. Inclusion in this directory is not an endorsement.